Three highly rated stocks in the No. 1 Biomed/Biotech industry group are getting close to buy points: Ligand Pharmaceuticals (LGND), Amgen (AMGN) and Alexion Pharmaceuticals (ALXN). Watch this video to find out what their buy points are — you may want to add them to your stock watch list. Follow Alissa Williams on Twitter: @IBD_AWilliams.
Akorn (AKRX) shares made big gains in the stock market today. The drugmaker had to restate its Q2 and Q3 2014 financial statements because of an error that led to an overstatement of revenue and earnings in Q2. But investors seem to be relieved by the move. Watch this video for a breakdown of this highly rated stock’s chart action. Other drug stocks that moved on big news this week include Regeneron (REGN), Amgen (AMGN), Sanofi (SNY), Esperion
Shares of several drugmakers soared Monday after a study published over the weekend said that their next-generation cholesterol drugs could cut the risk of heart disease, which is the world’s No. 1 killer. Highly rated Regeneron (REGN) broke out, and closed Monday’s session still in buy range. Its drug development partner Sanofi (SNY) rose on the news too. So did Amgen (AMGN), whose own heart disease treatment also showed positive results. Watch